During the past decade, Redcliffe Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Redcliffe Hospital" #1 sponsor was "Australian and New Zealand Intensive Care Research Centre" with 5 trials, followed by "The George Institute" with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "Bavarian Nordic" with 1 trials sponsored and "CSL Limited" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Redcliffe Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 6 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 3 trials as a collaborator, "Medical Research Institute of New Zealand" with 3 trials as a collaborator, "ANZICS Clinical Trials Group" with 2 trials as a collaborator and "Baxter Healthcare Corporation" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Redcliffe Hospital" are "Bacteremia" (2 trials), "Cardiovascular Disease" (2 trials), "Critical Illness" (2 trials), "Critically Ill" (2 trials) and "Melanoma" (2 trials). Many other conditions were trialed in "Redcliffe Hospital" in a lesser frequency.

Most popular intervention types in "Redcliffe Hospital" are "Drug" (14 trials), "Other" (5 trials), "Biological" (3 trials), "Behavioral" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "0.9% sodium chloride" (1 trials), "ARB + DMX-200" (1 trials) and "Amoxicillin-clavulanate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Redcliffe Hospital" are 22 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Redcliffe Hospital". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in Redcliffe Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Redcliffe Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".